TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia

Pediatr Blood Cancer. 2021 Jan;68(1):e28542. doi: 10.1002/pbc.28542. Epub 2020 Aug 2.

Karin Langenberg-Ververgaert¹, Samuele Renzi^{2

3}, Fabio Fuligni⁴, Scott Davidson⁴, Mohamed Abdelhaleem^{5

6}, Winnie Lo⁴, David Malkin^{2

3

4}, Adam Shlien^{4

5}, Mary Shago^{5

6}, Anita Villani^{2

3

4}, Oussama Abla^{2

3}

¹ Department of Translational Research, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
² Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
³ Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
⁴ Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
⁵ Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
⁶ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Publication types